According to the website of the National Medical Products Administration, on December 10th, the National Medical Products Administration held a national meeting in Fuzhou to consolidate and enhance the "Clean Source" action for drug management. Since the beginning of this year, drug regulatory departments in various regions have focused on channel compliance, product legality, and process traceability, and have deeply promoted the "Clean Source" action. The effectiveness of drug information traceability applications has gradually emerged, and the standardization of online and offline sales has continued to improve. A total of 32000 illegal and irregular cases have been investigated and dealt with, and the action has achieved phased results. The meeting requires that all regions further expand the achievements of the "Clean Source" campaign, continuously cultivate high-quality business entities, innovate the supervision mechanism of drug online sales, empower daily supervision with technology, and work together to strengthen case investigation and handling efforts, continuously improving business supervision capabilities. (New Society)